Biosynthesis of the Angiogenesis Inhibitor Borrelidin by Streptomyces parvulus Tü4055: Cluster Analysis and Assignment of Functions by Olano Álvarez, Carlos et al.
Chemistry & Biology, Vol. 11, 87–97, January, 2004, 2004 Elsevier Science Ltd. All rights reserved. DOI 10.1016/j .chembiol .2003.12.018
Biosynthesis of the Angiogenesis Inhibitor
Borrelidin by Streptomyces parvulus Tu¨4055:
Cluster Analysis and Assignment of Functions
transferase (AT) and the acyl carrier protein (ACP) do-
mains present in each module are responsible for the
choice of extender unit and the retention of the growing
chain and its transfer on the PKS, respectively. In addi-
tion, modules of type I PKSs may contain domains with
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Borrelidin (bor) is an 18-membered macrolide pro-
duced by several streptomycete species. The structureSummary
of borrelidin (Figure 1) was first elucidated in 1967 [5],
then subsequently refined by detailed NMR analysis andThe biosynthetic gene cluster for the angiogenesis
confirmed by X-ray crystallography [6, 7]. The previouslyinhibitor borrelidin has been cloned from Streptomy-
described antibiotic treponemycin was shown to beces parvulus Tu¨4055. Sequence analysis indicates that
identical to borrelidin [8]. Borrelidin was discovered duethe macrolide ring of borrelidin is formed by a modular
to its antibacterial activity [9, 10] that involves selectivepolyketide synthase (PKS) (borA1-A6), a result that
inhibition of threonyl tRNA synthetase [11], and it alsowas confirmed by disruption of borA3. The borrelidin
exhibits antiviral activity [12]. The recent discovery ofPKS is striking because only seven rather than the
antiangiogenesis activity highlights the potential of bor-nine modules expected for a nonaketide product are
relidin as a therapeutic agent [13]. Angiogenesis is theencoded by borA1-A6. The starter unit of the PKS has
formation of new vascular networks, and many inhibitorsbeen verified as trans-cyclopentane-1,2-dicarboxylic
of the complex pathways involved in this process areacid (trans-1,2-CPDA), and the genes involved in its
being studied as potential targeted therapeutics for can-biosynthesis identified. Other genes responsible for
cer chemotherapy. Tumor angiogenesis is provoked bybiosynthesis of the nitrile moiety, regulation, and self-
the tumor responding to hypoxia, and the downstreamresistance were also identified.
consequences of this are mostly host-derived pro-
cesses. Targeting tumor angiogenesis avoids the hur-
Introduction dles of other anticancer therapeutic modalities, such as
the diversity of cancer types and drug resistance [14].
Macrolide antibiotics are a large and structurally diverse In addition to its potent angiogenesis-inhibiting activ-
class of natural products that includes compounds pos- ity, borrelidin was shown to possess antiproliferative
sessing potent and valuable therapeutic activities. Poly- activity toward various cell lines. Borrelidin inhibits tRNA
ketide macrolides are synthesized through the repeated synthetase and protein synthesis in cultured rat cells.
condensation of simple carboxylic acid units in a pro- However, the IC50 value for antiangiogenesis activity is
cess closely resembling that of fatty acid biosynthesis. 50-fold lower than that reported for inhibition of protein
Their biosynthesis is catalyzed by polyfunctional type-I synthesis, indicating that these represent different activ-
polyketide synthases (PKSs), also called modular PKSs, ities of the compound [13]. Borrelidin has also been
which are organized into repeating modules. Each mod- identified as an inhibitor of cyclin-dependant kinase
ule consists of the set of catalytic “domains” required Cdc28/Cln2 of Saccharomyces cerivisiae. It was found
to perform one round of chain assembly. Condensation to arrest both haploid and diploid cells in late G1 phase
of the next extender carboxylic acid unit onto the grow- at concentrations that do not affect gross protein bio-
ing polyketide chain is performed by the catalytic activity synthesis [15]. Present available data therefore indicate
of the essential -ketosynthase (KS) domain. The acyl that borrelidin has potential as a lead compound to de-
velop anti-tumor agents. This is reflected in the number
of groups attempting synthetic programs toward borreli-*Correspondence: jasalas@correo.uniovi.es
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were identified, covering, in total, a chromosomal length
of approximately 140 kb.
The complete nucleotide sequence of two of these over-
lapping cosmid clones, cosBor32A2 and cosBor19B9,
was determined (EMBL accession number AJ580915).
Analysis of the sequence revealed the presence of 42
ORFs. All of them showed the high GC content and
GC bias in the third codon position that is characteris-
tic of Streptomyces genes. Analysis of the deduced
products of the different ORFs revealed the similarities
Figure 1. Structure of Borrelidin shown in Table 1. Several ORFs (borA1-borA6) appear
to encode for proteins that, based on the similarities to
the conserved amino acid sequences of modular PKSs,
din, with the first total synthesis reported recently by clearly suggested their involvement in borrelidin biosyn-
the Morken group [16]. thesis. Some genes flanking the PKS genes were also
Here, we report the cloning, sequencing, and charac- assigned to be involved in borrelidin biosynthesis based
terization of the biosynthetic gene cluster for borrelidin on (1) comparison to proteins in databases and ad-
in Streptomyces parvulus Tu¨4055. The cluster com- scription of putative functions in borrelidin biosynthesis
prises genes encoding a type-I PKS, genes participating and (2) generation of mutants by gene disruption/
in the biosynthesis of the unusual starter unit trans- replacement with the loss of the capability to produce
cyclopentane (1R,2R )-dicarboxylic acid (trans-1,2-CPDA), borrelidin (see below). Some other ORFs (B1, B2, B11
genes involved in further modification of the polyketide, to B17, B22; indicated in white in Figure 2) either did
and a borrelidin self-resistance gene. Insertional inacti- not show significant similarities to proteins in databases
vation mutants were generated for every non-PKS gene that would suggest a role for these proteins in borrelidin
within the biosynthetic gene cluster. Further, each mu- biosynthesis or their putative functions were found not
tant strain was complemented in trans by the addition to be necessary for borrelidin biosynthesis. In addition,
of a full-length copy of the inactivated gene, and each several other ORFs (indicated in gray in Figure 2) showed
was chemically complemented through the addition of significant similarities to proteins from Streptomyces
exogenous trans-1,2-CPDA where appropriate. This coelicolor A3(2) (a borrelidin nonproducer), either show-
leads to a detailed proposal for borrelidin biosynthesis ing the same genetic organization as in S. coelicolor
with a functional assignment of the gene products from A3(2) (B8 to B10) or showing a different genetic arrange-
the cluster. ment (B3 to B7 and B18 to B21). The disruption of borB2
did not affect borrelidin production (data not shown).
Results Based on these considerations, the ORFs indicated by
the letter B (Figure 2) were tentatively excluded as being
Cloning and Sequencing of the Borrelidin part of the borrelidin gene cluster, thus establishing the
Gene Cluster limits of the biosynthetic gene cluster.
A cosmid library of S. parvulus Tu¨4055 genomic DNA
was screened by in situ colony hybridization using as a
Organization of the Borrelidin Gene Clusterprobe the 1.7 kb BglII-BamHI fragment of ORFB from
Genes proposed to encode enzymes involved in borreli-Streptomyces antibioticus ATCC11891 [17]. This gene
din biosynthesis span a region of approximately 52 kb.encodes the third subunit of the oleandomycin PKS and
Six genes (borA1-A6) coding for the PKS are located incontains the coding region for the KS domain of module
the middle of the cluster. Flanking the PKS genes on6. Several positive clones were isolated and verified by
the left-hand side and transcribed in the opposite direc-Southern hybridization using the same probe as above.
tion, are seven genes (borB, borC, borD, borE, borF,To test the possible involvement of these cosmids in
borG and borH). To the right-hand side of the PKS genesborrelidin biosynthesis, two BamHI fragments (2.8 and
and transcribed in the same direction are six additional2.0 kb) from cosmid Bor32A2 were subcloned into the
genes (borI, borJ, borK, borL, borM, borN and borO)suicide vector pOJ260, and the resultant constructs
(Figure 2). Some genes may be translationally coupled(pOJM7 and pOJM8) were used for gene disruption ex-
as they include overlapping stop and start codons (borBperiments. These constructs were used to transform
and borC, borD and borE, borE and borF, borG andS. parvulus Tu¨4055 protoplasts, and the resultant apra-
borH, borA3 and borA4, borA4 and borA5, borA5 andmycin-resistant strains were tested for their ability to
borA6, borA6 and borI, borJ and borK).produce borrelidin. HPLC analysis revealed both strains,
designated as SPM7 and SPM8, respectively, to be defi-
cient in borrelidin production. DNA sequencing later re- Polyketide Synthase Genes
Six genes, borA1 to borA6, encode a type I PKS con-vealed that the two fragments used to generate the
disruptants are adjacent to each other within the bor taining a total of 31 individual domains organized into
a loading module and six extender modules (Figure 3).PKS. These experiments demonstrated that the cloned
DNA region is involved in borrelidin biosynthesis. Sev- All six genes are arranged head-to-tail and transcribed
in the same direction. No apparent transcriptional termi-eral fragments of DNA that originate from the ends of
the insert in cosmid Bor32A2 were used to screen the nator sequences were observed through DNA sequence
analysis. Strikingly, sequence analysis of the DNA regioncosmid library. Ten new overlapping cosmid clones
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coding for the borrelidin PKS revealed several long re- codes the final extension unit, which incorporates malo-
nyl-CoA and also contains the chain-terminating thioes-peated sequences (Figure 3). A region of 1001 bp was
found to be repeated within borA2 (module 1), borA3 terase domain (TE).
Curiously, although borrelidin is a nonaketide (which(module 2), and borA6 (module 8). These repeated se-
quences comprise most of the coding regions for malo- should require one loading plus eight extension steps),
only seven modules are present in the cluster (one load-nyl-specific AT domains and are identical in the three
modules with the exception of 2 bp. Furthermore, mod- ing and six extension modules) as encoded by genes
borA1 to borA6 (Figure 4). The possibility that DNA re-ules 1 and 8 also share an additional DNA region of 168
bp of identity. Similarly, another DNA region of 803 bp arrangements could have occurred during construction
of the cosmid library was excluded by extensive South-is repeated within borA3 (module 3), borA4 (module 4),
and borA5 (module 5) with only one bp change (in mod- ern hybridization analysis both in S. parvulus Tu¨4055
and in two other borrelidin producing streptomycetesule 5). Most of the coding regions for the KS and meth-
ylmalonyl-specific AT domains were included within (data not shown). Therefore, there are two condensation
steps incorporating methylmalonate units for which nothese repeated sequences. Furthermore, modules 3 and
5 also share two identical regions of 560 and 304 bp modules could initially be assigned. The implications of
these findings are discussed below.located upstream and downstream, respectively, of the
803 bp region. The gene borB encodes a thioesterase. BorB shows
similarities to type II thioesterases such as PimI from S.The borA1 gene encodes the loading module. Assign-
ment of the start codon is not obvious for borA1. There nataliensis (49% identity; accession number CAC20922)
and RifR from Amycolatopsis mediterranei S699, (48%are four possible start codons prior to the beginning of
the AT0 domain sequence. The first start codon (position identity; accession number AAG52991). Type II thioes-
terases have been proposed to rid the PKS of aberrant16,184) leaves a significant N-terminal tail of 321 amino
acids preceding the AT0 domain. By comparison, the acyl chains that might otherwise block the enzyme com-
plex [20, 21]. In the case of the tylosin type II thioesteraseN-terminal tail preceding the AT0 of the erythromycin
PKS loading module is 108 amino acids, and that of the (Orf5), the in vitro behavior is consistent with its pro-
posed role as an editing enzyme [22]. Disruption of typeavermectin PKS loading module is 28 amino acids. It is
therefore possible that one of the other candidate start II thioesterases leads to a decreased level of polyketide
production [20, 21]. Similarly, we found a 25% decreasecodons could be correct (positions 16,298, 16,607, or
16,901). The length of the N-terminal tail suggests that in borrelidin production when borB was disrupted.
it could possibly contain a catalytic activity, although it
does not have any significant similarity to other se-
Genes Involved in the Biosynthesisquences in databases. The BorA1 protein contains two
of the Starter Unitdomains encoding for an AT0 and an ACP, respectively.
A retrobiosynthetic analysis of borrelidin suggests thatThe AT0 domain of the borrelidin PKS loading module
trans-cyclopentane-(1R,2R )-dicarboxylic acid (trans-1,2-diverges from the majority of PKS AT domains, as the
CPDA) may be the starter unit. This was confirmed byactive site contains a cysteine residue instead of the
feeding the commercially available racemate of this acidusually observed serine such that the active site motif
to strains deficient in starter biosynthesis (see below).is GXCXG (specifically GHCYG). To date, for most type
Several genes in the cluster located both upstream andI PKS AT domain sequences, the conserved active site
downstream of the PKS genes are potential candidatesmotif is GXSXG, which is the motif observed in lipases,
to be involved in starter unit biosynthesis (see Table 1fatty acid synthases, and most thioesterases.
for similarities). The borN gene product resembles anBorA2 (one module), BorA3 (two modules), BorA4,
isomerase involved in the production of 2-oxohepta-3-BorA5, and BorA6 (all containing one module) encode
ene-1,7-dioate, a key step in the catabolism of tyrosinethe remainder of the borrelidin PKS. All of them contain
via 4-hydroxyphenyl acetic acid (4HPA), which could beconserved KS and ACP domains. The AT domains for
an intermediate in the biosynthetic pathway to trans-these PKS extension modules display the active site
1,2-CPDA [23]. The borE product displays similarity tomotif GXSXG and also contain the expected motifs for
O-succinylbenzoyl-CoA synthase and chloromuconatethe selection of either malonyl-CoA or methylmalonyl-
cycloisomerases such as YkfB from Bacillus subtilisCoA [18, 19]. The malonyl-CoA selective AT domains
(26.2% identity; accession number AJ002571), which(AT1, AT2, and AT6) exhibit very high similarity to each
are enzymes belonging to the enolase superfamily.other both at the protein and DNA levels. The same is
Members of the enolase superfamily share the ability totrue for the methylmalonyl-CoA-selective AT domains
stabilize the formation of an anion on the carbon atom(AT3, AT4, and AT5); two of these AT domains (AT3 and
adjacent to a carboxylate group [24]. We therefore pro-AT4) have identical amino acid sequences throughout
pose that BorE may be required for the cyclization of athe conserved region. The high similarity of AT5 and
putative intermediate in the biosynthesis of the starterAT4 to AT3 provides evidence that the extender unit
unit. The borC, borD, borK, and borM genes could codeselected by module 3 is methylmalonyl-CoA, and it is
for oxidoreductases resembling 2,5-dichloro-2,5-cyclo-therefore most probable that the borrelidin C12-methyl
hexadiene-1,4-diol dehydrogenase, 3-oxoacyl-ACP re-group thus incorporated is subsequently modified to a
ductase, alcohol dehydrogenease Adh1, and F420-nitrile moiety after incorporation into the PKS. All exten-
dependent dehydrogenase, respectively (Table 1). Thesion modules contain a KR domain, modules 2 and 3
products of three other genes, borF, borG, and borH,include additional DH domains, and module 5 contains
DH and ER domains. The final PKS gene, borA6, en- did not show significant similarities with proteins in data-
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Table 1. Deduced Functions for Genes in the Borrelidin Gene Cluster
Proposed Function in
Gene Amino Acids Closest Similar Protein (% Identity/Similarity), Accession No. Borrelidin Biosynthesis
orfB1 103a Putative integral membrane protein SCE22.09 from S.coelicolor
(30/56), CAB90976
orfB2 868 Hypothetical protein SCM2.07 from S. coelicolor (85/91), CAB65635
orfB3 212 Hypothetical protein SCF76.07 from S. coelicolor (89/96), CAB56727
orfB4 329 Probable AraC transcriptional regulator SCF76.06 from S. coelicolor
(84/91), CAB56726
orfB5 276 Nonheme chloroperoxidase (EC 1.11.1.10) SCF76.05c from
S. coelicolor (89/94), CAB56725
orfB6 185 Hypothetical protein SCF76.09 from S. coelicolor (76/84), CAB56729
orfB7 323 Hypothetical protein SCF76.08c from S. coelicolor (80/88), CAB56728
borB 264 Type II thioesterase PteH from S. avermitilis (52/68), AB070949 type II thioesterase
borC 265 2,5-dichloro-2,5-cyclohexadiene-1,4.diol dehydrogenase XF1726 starter unit biosynthesis
from Xylella fastidiosa strain 9a5c (42/64), AAF84535
borD 250 3-oxoacyl-ACP reductase FabG from Plasmodium falciparum starter unit biosynthesis
(31/53), AF237573
borE 390 O-succinylbenzoate-CoA synthase FN1586 from Fusobacterium starter unit biosynthesis.
nucleatum subsp. nucleatum (27/51), AAL93701
borF 272 Putative lysophospholipase homolog At1g73480 from Arabidopsis starter unit biosynthesis
thaliana (26/49), AY045929
borG 539 Acetolactate synthase, large subunit, MTH1444 from Methanother- starter unit biosynthesis
mobacter thermautotrophicus (30/52), AAB85919
borH 675 Hypothetical protein PA3592 from Pseudomonas aeruginosa (31/54), starter unit biosynthesis
AAG06980
borA1 876 Polyketide synthase loading and extender module 1, SpnA from PKS loading domain (AT-ACP)
Saccharopolyspora spinosa (41/62), AAG23264
borA2 1571 Modular polyketide synthase PteA4 from S. avermitilis (54/72), PKS module 1(KS-ATa-KR-ACP)
BAB69306
borA3 3500 Modular polyketide synthase PteA2 from S. avermitilis (55/72), PKS modules 2 and 3 (KS-ATa-DH-KR-
BAB69304 ACP-KS-ATp-DH-KR-ACP)
borA4 1620 Modular polyketide synthase OlmA7 from S. avermitilis (54/71), PKS module 4 (KS-ATp-KR-ACP)
BAB69196
borA5 2156 Soraphen polyketide synthase SorA from Polyangium cellulosum PKS module 5 (KS-ATp-DH-ER-KR-ACP)
(51/69), AAK19883
borA6 1742 Modular polyketide synthase PteA5 from S. avermitilis (50/68), PKS module 8 (KS-ATa-KR-ACP-TE)
BAB69307
borI 426 Cytochrome P450 TylH1 from S. fradiae (41/63), AAD12167 nitrile biosynthesis
borJ 454 DAPA aminotransferase BioA from Kurthia sp (39/62), BAB39453 nitrile biosynthesis
borK 330 Alcohol dehydrogenase Adh1 from Aquifex aerolicusv (36/56), unknown
AAC07327
borL 446 Putative auxin-regulated protein GH3 At1g59500 from Arabidopsis starter unit biosynthesis
thaliana (24/49), NP_176159
borM 305 Hypothetical protein SCL6.10 from S. coelicolor similar to putative starter unit biosynthesis
F420-dependent dehydrogenase (36/54), CAB76875
borN 248 Hypothetical protein SC1C2.27 from S. coelicolor, 2-hydroxyhepta- starter unit biosynthesis
2,4-diene-1,7-dioate isomerase superfamily (48/65),CAB55708
borO 675 Protein ThrS from Mycobacterium tuberculosis H37Rv, similar to borrelidin resistance
threonyl-tRNA synthetase (50/69), CAB08628
orfB8 126 Hypothetical protein SC5E9.01c from S. coelicolor (81/86), CAC14481
orfB9 127 Putative anti-sigma factor antagonist SC5E9.02 from S. coelicolor
(54/68), CAC14482
orfB10 82 Hypothetical protein SC5E9.03 from S. coelicolor (79/88), CAC14483
orfB11 70 Hypothetical, no hits.
orfB12 172 Putative regulator of the two componen systems SC5C11.03 from
S. coelicolor (41/57), CAB76309
orfB13 163 Putative acetyltransferase SCM2.08c from S. coelicolor (68/78),
CAB65636
orfB14 638 Putative secreted protein SC8A11.15c from S. coelicolor (51/67),
CAC01587
orfB15 165 Hypothetical protein SC9H11.25c from S. coelicolor (29/48),
CAB92214
orfB16 783 Putative oxidoreductase SCBAC25F8.17 from S. coelicolor (84/91),
CAC42152
orfB17 177 Conserved hypothetical protein SCBAC25F8.16 from S. coelicolor
(58/73), CAC42151






Gene Amino Acids Closest Similar Protein (% Identity/Similarity), Accession No. Borrelidin Biosynthesis
orfB19 467 Putative aldehyde dehydrogenase AldA from S. aureofaciens (87/92),
AAD23400
orfB20 370 Putative aldehyde dehydrogenase SC9B5.09 from S. coelicolor
(77/87), CAA22751
orfB21 301 Hypothetical protein SC9B5.10 from S. coelicolor (71/80), CAA22752
orfB22 180 Putative calcium binding protein SC10F4.20 from S. coelicolor
(58/69), CAC16980
a Incomplete ORF.
bases that can suggest a defined role in starter unit be involved in the biosynthesis of trans-1,2-CPDA, but
these data and protein similarity searches do not sug-biosynthesis (Table 1). The borL product shows similar-
ity to auxin response proteins from plants. Auxins are gest a role. However, it may be that these genes have
no role whatsoever in trans-1,2-CPDA biosynthesis, ashormones involved in the regulation of various cellular
processes in plants [25]. feeding the wild-type strain with exogenous starter acid
likewise increases the titer of borrelidin. The fact thatTo investigate the role of these genes in trans-1,2-
CPDA biosynthesis, individual mutants in all these genes the level of borrelidin production was increased by addi-
tion of trans-1,2-CPDA both in the different mutantswere generated by insertional inactivation. They were
inactivated in a manner designed to avoid the possibility and in the wild-type strain suggests that biosynthesis of
trans-1,2-CPDA might be a bottleneck during borrelidinof polar effects, which was verified in all cases by in
trans complementation with a full-length copy of the biosynthesis in this strain. Borrelidin production in-
creased when additional copies of genes borE and borLdisrupted gene under the control of the erythromycin
resistance promoter ermE*. Two groups of mutants were were introduced into S. parvulus Tu¨4055. The genes
were expressed in a multicopy plasmid vector underfound: (1) mutants in which borrelidin production was
abolished and (2) mutants in which borrelidin was pro- the control of the strong constitutive promoter ermE*.
Biosynthesis of borrelidin increased 4.2 0.3 and 4.3duced, but the yields were clearly diminished (75%–89%
decreased). The first group included mutants in borC, 0.7 fold upon expression of borE and borL, respectively,
when compared with the titer of borrelidin of the wild-borD, borE, borF, borK, borL, and borM, and the second
group included mutants in borG, borH, and borN. To type strain only containing the vector.
further investigate the participation of these genes in
trans-1,2-CPDA biosynthesis, feeding experiments were Genes Involved in the Formation
of the Nitrile Moietycarried out. The mutants were grown in the presence
of trans-1,2-CPDA, and borrelidin production was as- Borrelidin contains a nitrile moiety at C12 of the macro-
lide ring. Sequence analysis of the AT domain of the borsessed (Table 2). Mutants in the first group (genes borC,
borD, borE, borF, borK, borL, and borM) recovered the PKS module 3 in BorA3 indicates that the substrate
utilized for the third round of chain extension is meth-ability to synthesize borrelidin after trans-1,2-CPDA ad-
dition, and the levels of production were similar or even ylmalonyl-CoA (see above). Thus, the carbon atom of
the nitrile moiety most probably arises from the methylhigher than in the wild-type strain. Mutants in the second
group (genes borG, borH, and borN) clearly increased group of methylmalonyl-CoA. The products of the genes
borI and borJ may be required for the formation of thetheir levels of production, even exceeding, in most
cases, the levels of the wild-type strain. Consequently, nitrile moiety at C12. The borI gene product would en-
code a cytochrome P450 hydroxylase. BorI shares theit can be deduced that genes borC, borD, borE, borF,
borK, borL, and borM are essential for starter acid bio- highest similarities with TylHI, which catalyzes the hy-
droxylation of an exocyclic methyl group of the tylosinsynthesis. The genes borG, borH, and borN may well
Figure 2. Schematic Representation of the
Borrelidin Gene Cluster
B, BamHI. ORFs involved in borrelidin bio-
synthesis are colored in black and those not
involved in gray or white, the gray ones corre-
sponding to homologous genes in S. coelico-
lor showing the same genetic organization.
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Figure 3. Scheme Representing the Repeated DNA Sequences within the Borrelidin PKS Genes
macrolactone prior to addition of a deoxyhexose moiety din at the activated C28-position, probably via a C12-
formyl moiety. Mutants obtained by disruption of these(41% identity, accession number AAD41818), SuaC from
S. griseolus (39% identity; accession number AAA26823), genes failed to make any borrelidin, and experiments
are underway in our laboratories to investigate the for-and P-450sca-2 from S. carbophilus, involved in prava-
statin biosynthesis (38% identity; accession number mation of the nitrile moiety.
BAA06492). BorI is therefore proposed to catalyze oxi-
dation of the C12-methyl group during borrelidin biosyn- Borrelidin Resistance
The borO gene product resembles different threonyl-thesis. The borJ gene resembles different PLP-depen-
dent aminotransferases with the highest similarities with tRNA synthetases, such as ThrS from S. coelicolor A3(2)
(50% identity; accession number NP_625810). It hasBioA from Kurthia sp. 538-KA26 (39% identity; acces-
sion number BAB39453), aminotransferase class III en- been shown that threonyl-tRNA synthetase is a molecu-
lar target for borrelidin in several bacterial strains [11],coded by gene BA_4800 from Bacillus anthracis A2012
(38% identity; accession number NP_658160), and ad- and, most probably, self-resistance of S. parvulus to
borrelidin is due to the product of borO, which wouldenosylmethionine-8-amino-7-oxononanoate aminotrans-
ferase BioA from Bacillus subtilis (40% identity; acces- encode a borrelidin-resistant threonyl-tRNA synthetase.
Expression of borO in S. albus J1074 confers resistancesion number BAC03240). BorJ is therefore proposed to
catalyze the introduction of a nitrogen atom into borreli- to this organism to borrelidin (data not shown).
Figure 4. Module Organization in the Borrelidin PKS and Proposed Model for Borrelidin Biosynthesis
ACP, acyl carrier protein; AT, acyltransferase; ATa, malonyl-specific acyltransferase; ATp, methylmalonyl-specific acyltransferase; ER, enoyl
reductase; KR, -keto reductase; DH, dehydratase; KS, -ketoacyl-acylcarrier protein synthase; TE, thioesterase.
Borrelidin Gene Cluster
93
Table 2. Production of Borrelidin by Different Mutants in the Borrelidin Gene Cluster
Borrelidin Productiona
Gene Plasmid Mutant strain No Addition Plus trans-1,2-CPDA
wild-type – – 100  16 363  65
borC pSLCr1 SPMC 0 933  42
borD pSLDr1 SPMD 0 75  15
borE pOJEd1 SPME 2  1 122  23
borF pLHFr1 SPMF 3  2 201  52
borG pOJGd1 SPMG 11  1 1532  142
borH pOJHd2 SPMH-2 17  2 203  40
borL pSLLr1 SPML 0 408  70
borK pSLKr1 SPMK 6  1 468  18
borM pSLMr1 SPMM 0 461  29
borN pSLNr1 SPMN 25  9 68  12
a % relative to wild-type S. parvulus Tu¨4055 levels of borrelidin production.
Discussion have been shown to accept a number of alternative
starter acids [31, 32], and notably, the avermectin load-
ing module can accept cyclopentane monocarboxylicIt is apparent from a retrobiosynthetic analysis that bor-
relidin biosynthesis includes several novel features, in- acid and cyclopent-1-ene monocarboxylic acid [31]. The
AT domains of PKSs select a particular carboxylic acidcluding the use of a dicarboxylic acid for the starter acid
of a PKS and the incorporation of a nitrile moiety into unit as substrate. For extension modules, this selectivity
has been shown to correlate with certain signature mo-a macrolide aglycone, either during polyketide assembly
or as a post-PKS modification. The biosynthetic gene tifs within AT domains [18, 19]. These motifs are not
conserved in the AT of the bor loading module, whichcluster responsible for borrelidin biosynthesis has been
cloned and sequenced from the producing strain S. par- is not surprising as this AT domain is the first to be
sequenced that selects an alicyclic dicarboxylic acid. Avulus Tu¨4055 and has uncovered fascinating aspects of
borrelidin biosynthesis at the molecular biology level. A further unusual aspect of the AT domain of the bor load-
ing module is that the active site contains a GXCXGtotal of 20 genes (spanning 52,369 bp) have been identi-
fied that have a role in borrelidin biosynthesis. All of motif rather than the usual GXSXG. Substitution of the
nucleophilic active site serine residue by cysteine is alsothese genes, with the exception of some PKS genes,
have been inactivated through insertional mutation and known for two NRPS thioesterase domains, specifically
those of the synthetases responsible for the productionsubsequently complemented in trans to preclude the
presence of polar effects when studying the phenotypes of mycobactin and pyochelin [33]. A GXCXG motif is
also observed in a thioesterase-like domain of ORF1 inof gene inactivated strains. Based on sequence similari-
ties, insertional inactivation, and feeding experiments, the bialaphos cluster [34]. Since it is not possible to
interconvert between the two types of serine codon viathese genes fall into four broad categories: those in-
volved in biosynthesis of the borrelidin polyketide back- a single base change, it has been suggested that active
sites containing an essential serine residue lie on twobone (i.e., the bor PKS), those involved in starter acid
biosynthesis, those involved in formation of the nitrile lines of descent from an ancient ancestral enzyme that
had a cysteine instead of a serine in its active site [35].moiety, and finally, those involved in regulation or resis-
tance. The presence of enzymes containing cysteine in the
active site may support this view. It may alternativelyThe bor PKS constitutes six polypeptides containing
a total of seven modules, and only BorA3, comprised be the case that cysteine arises in these active sites
because it is possible to mutate from one type of serineof extension modules 2 and 3, is bimodular. All the re-
maining modules, including the loading module, exist as codon to the other via a cysteine, which would remain
catalytically active.discrete proteins (Figure 3). More commonly, the loading
module is found together with the first extension module The identification of catalytic domains and determina-
tion of their boundaries in the bor PKS were based onon one protein. The streptomycete-derived polyene
macrolides nystatin [26] and amphotericin [27] and the similarities to the conserved amino acid sequences of
other modular type I PKSs. All of the individual enzymaticmyxobacterial epothilone [28] PKSs also exhibit this fea-
ture with bor. Many different starter units have been domains appear to be catalytically active, based both
on their amino acid sequences and on the amount ofreported to be incorporated by loading domains of PKS
[29]. The discrete bor PKS loading module selects and reductive processing required for each module based
on a retrobiosynthetic analysis. This situation is rare, aspresents trans-cyclopentane-(1R,2R )-dicarboxylic acid
(trans-1,2-CPDA) to the first extension module and rep- modular type-I PKSs tend to include one or more inac-
tive domains. A precedent for this is the spinosyn PKS,resents the first loading module to be sequenced that
naturally selects a dicarboxylic acid. The coronatine which likewise contains no inactive domains [36].
A particularly striking aspect of the bor PKS is thePKS incorporates a five-membered alicyclic monocar-
boxylic acid, namely 2-carboxycyclopent-2-eneone absence of two extension modules that would be re-
quired by the “one module, one extension” colinearity[30]. However, borA1 is more similar to the loading mod-
ules of the avermectin and erythromycin PKSs. These paradigm. Borrelidin contains a hydrophobic 1,3,5-tri-
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methylhexyl moiety between positions C4 to C9 that borN (see Table 2 and Results). Putative functions have
been assigned to these genes (see Table 1 for similari-requires three consecutive chain extensions, utilizing
methylmalonyl-CoA as substrate, together with com- ties). Of particular interest is borE, a member of the
enolase superfamily and therefore potentially able toplete reduction (i.e., involving KR, DH, and ER domains)
of the -keto moiety generated during each chain exten- stabilize the formation of a carbanion on the carbon
adjacent to a carboxylate. It is reasonable to suggestsion cycle. Only BorA5 contains all three reductive do-
mains, and furthermore the AT of this module selects that such a step may be involved in the formation of the
cyclopentane ring by generating an -carboxyl carban-for methylmalonyl-CoA. It could be possible that the
bor PKS utilizes module 5 through three distinct chain ion nucleophile (or equivalent) that could undergo inter-
molecular attack at an activated carbon at C2 (activatedextension cycles on one nascent acyl chain. If this is
indeed the case, then to the best of our knowledge as either a carbonyl or phosphorylated secondary alco-
hol) (see Figure 5).this represents only the third example in which a type I
modular PKS contains a module that appears to be used Hypothetically, the biosynthesis of trans-1,2-CPDA
may originate from tyrosine catabolism. The product ofiteratively (i.e., as opposed to aberrant iterative use of
one module, referred to as “stuttering” [37, 38]), the borN exhibits homology to 2-hydroxyhept-2,4-diene-
1,7-dioate isomerase, a key enzyme in 4-hydroxyphenyl-other cases being the PKSs responsible for stigmatellin
[39] and lankacidin [40] biosynthesis. However, in all of acetic acid catabolism, which is itself a product of ty-
rosine catabolism. BorN may catalyze the isomerasethese cases, this conjecture is only based on compari-
son of molecular structure with the respective biosyn- reaction for which the homolog has been characterized,
i.e., the production of 2-oxohept-3-ene-1,7-dioate (Fig-thetic gene cluster, and no functional evidence has yet
been presented. Recently, we have shown that engi- ure 5), with the conjugated double bond then being re-
duced by BorK or BorM. Either BorC or BorD couldneered gene fusions of the bor PKS genes in which
module 5 was translationally fused to either or both reduce the keto group at C2, and the resultant hydroxyl
could be phosphorylated by the action of BorF. 2-phos-flanking modules (module 4 encoded by borA4 and mod-
ule 8 encoded by borA6) remained able to synthesize phoheptane-1,7-dioate could then be cyclized (as de-
scribed above) by the action of BorE to yield trans-1,2-borrelidin [41]. These experiments indicate that it is un-
likely that PKS modules encoded elsewhere on the ge- CPDA. This scheme would then require thioesterification
by coenzyme A in order to generate the activated sub-nome are involved in borrelidin biosynthesis. Addition-
ally, it appears improbable, based on these data, that strate for the bor loading module. Since BorN would
catalyze a reaction that is essentially one of primarythree separate copies of BorA5 dock together and cata-
lyze three independent rounds of chain extension in a metabolism, its function may be to channel substrate
into trans-1,2-CPDA biosynthesis, thus forming a novelprocessive manner. BorA5 therefore operates itera-
tively, although the specific mechanism governing its link between primary and secondary metabolism. When
borN is inactivated, borrelidin, and hence trans-1,2-functionality remains to be uncovered [41].
The bor extension modules 1, 2, and 8 all incorporate CPDA, is still biosynthesised, albeit at a reduced rate.
This could be explained if 2-oxohept-3-ene-1,7-dioatemalonyl-CoA and, strikingly, feature near total identity
of the AT domains both at the amino acid and nucleotide produced via primary metabolism is utilized during
trans-1,2-CPDA biosynthesis.level. The AT domains of modules 4, 5, and 8, which
select for methylmalonyl-CoA, likewise display a very The hypothesis for trans-1,2-CPDA biosynthesis pre-
sented above is consistent with the genes shown tohigh level of sequence identity. The presence of these
repeated regions may explain the deletions frequently have a role in trans-1,2-CPDA biosynthesis, although
clearly other biosynthetic routes are possible. The bio-observed while genetically manipulating S. parvulus
Tu¨4055 (C.O., unpublished results). synthesis of trans-1,2-CPDA is currently being studied
in our laboratories through precursor feeding and heter-The starter acid for borrelidin biosynthesis is trans-
cyclopentane-1,2-dicarboxylic acid, as confirmed by ologous gene expression studies.
Feeding exogenous trans-1,2-CPDA (1 mM) to wild-feeding the commercially available racemate of this
acid. Based on the absolute stereochemistry of borreli- type S. parvulus Tu¨4055 increased the yield of borrelidin
3.6  0.6 fold, implying that starter acid biosynthesis isdin [6,7], trans-cyclopentane-(1R,2R )-dicarboxylic acid
is the starter unit accepted by the bor loading module. a bottleneck in borrelidin biosynthesis. Feeding trans-
1,2-CPDA to all the mutants disrupted in one of theFurthermore, racemic cis-cyclopentane-1,2-dicarbox-
ylic acid, fed as the monoethylester (the trans equivalent genes putatively involved in trans-1,2-CPDA biosynthe-
sis (i.e., borC, borD, borE, borF, borG, borH, borK, borL,of which is an excellent substrate), did not contribute
to borrelidin biosynthesis in strains deficient in BorE borM, or borN; see Table 2) reestablished borrelidin
production, but to greatly different levels. No strong(unpublished results). The biosynthetic pathway to the
novel dicarboxylic acid starter unit trans-1,2-CPDA is sequence homologies were found for borG, although it
has a profound effect on borrelidin biosynthesis. Thecomplex. It has been resolved in part through gene inac-
tivation with subsequent complementation in trans of mutant containing a disrupted copy of borG loses most,
though not all, of its ability to produce borrelidin. How-the full-length gene and through feeding with exogenous
trans-1,2-CPDA to these mutants. A number of genes ever, feeding this strain with exogenous starter acid
increases the yield relative to wild-type 15.3  1.3 foldwere identified to be essential for trans-1,2-CPDA pro-
duction: borC, borD, borE, borF, borK, borL, and borM. (see Table 2). No functional or structural role could be
assigned to borG in trans-1,2-CPDA production, but theA further set of genes were found that may well have a
role in trans-1,2-CPDA biosynthesis: borG, borH, and 15-fold increase in borrelidin titer described above sug-
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Figure 5. Putative Biosynthetic Pathway for Trans-1,2-CPDA from 4HPA
gests that borG may be involved in the regulation of larities, insertional inactivation, and feeding experi-
ments to be involved in the biosynthesis of the startertrans-1,2-CPDA biosynthesis. A second gene likely to
regulate trans-1,2-CPDA biosynthesis is borL, whose unit. The identification of the borrelidin cluster opens
up a way for future studies aimed at engineering moredisruption leads to a borrelidin nonproducer. Although
showing no strong resemblance to known bacterial pro- potent analogs of borrelidin as angiogenesis inhibitors
and antitumor agents through combinatorial biosyn-teins, it does demonstrate weak homology with the puta-
tive regulatory bacterial proteins from the IclR and GntR thesis.
families in S. coelicolor A3(2) (accession numbers
Experimental ProceduresNP_628363 and NP_624887). The strongest match for
BorL corresponds to auxin-responsive proteins from
Strains, Culture Conditions, and Plasmids
plants, specifically Arabidopsis thaliana. Auxins are S. parvulus Tu¨4055 and mutants were routinely grown on tryptone
plant hormones, and to the best of our knowledge auxins soya broth (TSB). Production, transformation, and regeneration of
and auxin-response proteins have not been observed protoplasts were performed following standard procedures [42].
Streptomyces albus J1074 [42] was used as host for expression ofin bacteria.
the borrelidin-resistance gene. When antibiotic selection of trans-The work presented here has revealed a number of
formants was required, 100 g/ml ampicillin, 20 g/ml tobramycin,unusual and interesting aspects of borrelidin biosynthe-
25 g/ml apramycin, and 50 g/ml hygromycin were used when
sis and has highlighted remaining issues that will require necessary.
further study through a combination of chemical, bio-
chemical, and genetic analysis. These include details DNA Manipulation
DNA manipulations were performed according to standard proce-of trans-1,2-CPDA biosynthesis, formation of the nitrile
dures for E. coli [43] and Streptomyces [42]. A cosmid library of S.moiety, and the apparently iterative use of a type I modu-
parvulus Tu¨4055 genomic DNA was constructed. DNA fragmentslar PKS module. It has also set the stage for a drug
obtained from a partial digestion with Sau3AI were ligated to cosmid
discovery program in which novel analogs of borrelidin pWE15 digested with BamHI and in vitro packaged using the Giga-
can now be generated through genetic engineering of pack III Gold packaging Extract kit according to the manufacturer’s
the biosynthetic genes. handbook (Stratagene). A number of the resulting E. coli transduc-
tants (3300 colonies) were picked and transferred to 96-well microti-
tre plates containing Luria broth (LB) medium and 100g/ml ampicil-
Significance lin. Clones were replica plated onto Luria agar (LA) plates containing
ampicillin. After overnight growth at 37C, colonies were transferred
to nylon membrane filters for in situ colony hybridization analysisMacrocyclic polyketides include some of the most im-
according to published methods [43] and screened using a labeledportant pharmaceutical agents in current clinical use.
probe that was generated using the DIG DNA labeling and detectionAlthough discovered because of its antibiotic activity,
kit (Roche).
borrelidin, a nonglycosylated 18-membered macro-
lide, has been recently “rediscovered” due to its anti- Sequencing of the Borrelidin Gene Cluster
angiogenesis activity and ability to induce apoptosis Cosmids Bor32A2 and Bor19B9 were sequenced by shotgun se-
quencing of a Sau3AI-derived subclone library for each cosmid,of capillary-forming cells, and therefore it has (or its
consisting of 1.5–2.0 kb fragments in pHSG397. DNA sequencingderivatives have) great potential as future cancer treat-
was carried out using an Applied Biosystems 800 Molecular Biologyments. Borrelidin also possesses several unique chemi-
CATALYST robot to perform the dideoxy termination reactions,cal features, including a nitrile moiety at C12 and an which were then loaded into an ABI Prism 3700 automated se-
unusual starter unit of the polyketide chain at C17 quencer (Applied Biosystems). The raw sequence data were pro-
(a trans-1,2-disubstituted cyclopentane dicarboxylic cessed using the Staden software package. Assembly and contig
editing was performed using GAP (Genome Assembly Program) ver-acid). The characterization of the borrelidin biosyn-
sion 4.2 [44].thetic gene cluster isolated from Streptomyces parvu-
lus Tu¨4055 has shown that its macrolide ring is formed
Generation of Mutants in S. parvulus Tu¨4055by a modular polyketide synthase. Interestingly, only
To generate mutants in different genes of the borrelidin cluster,
seven rather than the nine modules expected for a several plasmids were constructed for gene replacement or gene
nonaketide product are encoded by the bor PKS. In disruption experiments. Primers used for PCR amplification of the
different genes and their flanking restriction sites are listed in theaddition, a set of genes were shown by sequence simi-
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